Allergic rhinitis
MONDO:0011786Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.
Also known as: allergic form of rhinitis, allergic rhinitis, Perenial allergic rhinitis, atopic rhinitis, non-seasonal allergic rhinitis, perennial allergic rhinitis, seasonal allergic rhinitis, Alrh
147 clinical trials for this condition and its sub-types, 96 tagged with Allergic rhinitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic rhinitis
-
Seasonal allergic rhinitis 45 trials
-
Perennial allergic rhinitis 28 trials
-
Vasomotor rhinitis 5 trials
-
Antiviral drug ganciclovir explored as new weapon against stubborn allergies
Disease control Recruiting nowThis trial investigates whether the antiviral drug ganciclovir can help people with moderate-to-severe allergic rhinitis that doesn't improve with standard treatments. Participants receive either ganciclovir capsules or a placebo for two weeks, alongside a nasal steroid spray. Re…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Dog allergy vaccine shows promise in small swedish trial
Disease control Recruiting nowThis study tests a dog allergy immunotherapy called Alutard SQ Dog in 40 adults with moderate-to-severe dog allergy. Participants receive increasing doses over 13 weeks, then maintenance shots every 6-8 weeks for a year. Their symptoms and lung function are measured before and af…
Phase 4 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New allergy shot aims to tame mugwort season in just four weeks
Disease control Recruiting nowThis Phase 2 trial tests PollenVax, a new immunotherapy for people with moderate-to-severe allergic rhinitis caused by mugwort pollen. The treatment is given as four weekly shots before the pollen season. Researchers will compare symptom scores and medication use between the Poll…
Phase 2 • Sponsor: Kazakh National Agrarian University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple seawater spray beat nasal congestion?
Symptom relief Recruiting nowThis study is testing a new seawater spray with essential oils to see if it safely relieves nasal congestion from colds, sinus infections, or allergies. About 101 people aged 12 and older will use the spray for 8 days. The main goal is to check if nasal stuffiness improves by at …
Sponsor: Laboratoires Gilbert • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can a simple seawater spray beat a stuffy nose?
Symptom relief Recruiting nowThis study is testing a seawater spray mixed with essential oils to see how well it relieves nasal congestion from colds, sinus infections, or allergies. About 114 people aged 12 and older will use the spray for 7 days. The main goal is to see if nasal blockage improves after 3 d…
Sponsor: Laboratoires Gilbert • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New allergy spray trial aims to help teens breathe easier
Symptom relief Recruiting nowThis study tests if Dymista nasal spray safely eases allergy symptoms like sneezing, stuffy nose, and itchy eyes in Chinese teenagers aged 12 to 17. About 100 participants will use the spray twice daily for two weeks. The goal is to see if symptoms improve, not to cure allergies.
Phase 4 • Sponsor: Viatris Inc. • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Ancient herbal blend put to the test against hay fever
Symptom relief Recruiting nowThis trial investigates whether Yupingfeng Powder, a traditional Chinese herbal formula, can improve symptoms and quality of life in adults with allergic rhinitis (hay fever). Participants will take the herbal granules or a placebo twice daily for 8 weeks, with follow-up for anot…
Phase 2/3 • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Video game aims to boost emotional health in teens with chronic diseases
Symptom relief Recruiting nowThis study is testing a serious video game designed to improve emotional well-being in teenagers aged 12 to 16, both with and without chronic conditions like type 1 diabetes, asthma, and allergies. The game uses artificial intelligence to personalize activities that build coping …
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
EATING YOUR WAY TO CLEARER SKIN? NEW STUDY TESTS DIET FOR ECZEMA
Symptom relief Recruiting nowThis study tests whether a diet low in saturated fats and rich in whole grains, fruits, and vegetables can reduce the severity of atopic dermatitis (eczema) in young adults. Researchers will track changes in skin symptoms and barrier function over two months. The goal is to see i…
Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New app aims to boost allergy treatment adherence
Symptom relief Recruiting nowThis study tests whether a mobile app can help people with allergic rhinitis (hay fever) stay on their allergy immunotherapy (allergy shots or under-the-tongue drops) for the full 3 years. Many people stop early, reducing the treatment's effectiveness. The app provides reminders …
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Cat allergy treatment gets a needle upgrade: fewer shots, same hope
Symptom relief Recruiting nowThis study tests a new method for treating cat allergies called intralymphatic immunotherapy (ILIT), where allergen extracts are injected directly into a lymph node. Thirty-six adults with cat-triggered allergic rhinitis and asthma will receive 3-4 ultrasound-guided injections. T…
Phase 1/2 • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New allergy shot alternative could ease sneezing and itchy eyes
Symptom relief Recruiting nowThis study tests a new under-the-tongue treatment (MM09) for people with rhinitis or rhinoconjunctivitis caused by house mite allergy, with or without mild asthma. About 736 participants aged 12 to 65 will receive either MM09 or a placebo to see if it reduces allergy symptoms and…
Phase 3 • Sponsor: Inmunotek S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Ocean in a bottle? new study tests seawater sprays for sinus relief
Symptom relief Recruiting nowThis study looks at how well seawater nasal sprays work in everyday life for people with nasal and sinus issues like colds, allergies, or after surgery. About 1065 people of all ages, including pregnant women, will use the sprays and report their symptoms. The goal is to see if t…
Sponsor: Laboratoire de la Mer • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
10,000 volunteers needed to unlock allergy mysteries
Knowledge-focused Recruiting nowThis study aims to collect blood, nasal fluid, skin cells, urine, and medical data from 10,000 people aged 3 to 100 with allergies, asthma, eczema, or sinus issues. Participants will have up to 3 years of follow-up visits and questionnaires. The goal is to create a large reposito…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New decision aid aims to reduce surgery regret for rhinitis patients
Knowledge-focused Recruiting nowThis study tests a printed decision aid that helps people with chronic hypertrophic rhinitis compare five surgical options. About 158 participants will either get standard counseling or the extra aid. Researchers will measure how certain patients feel about their choice and wheth…
Sponsor: Taipei Medical University Shuang Ho Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Nasal spray test could make allergy shots smarter and cheaper
Knowledge-focused Recruiting nowThis study is testing whether a nasal allergen provocation test (NAPT) can help doctors start and monitor allergy immunotherapy more effectively. Researchers will follow 200 adults with allergic rhinitis who are beginning immunotherapy, using the NAPT along with blood tests and s…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Can treating your mind and allergies together improve symptoms?
Knowledge-focused Recruiting nowThis study explores whether people who seek help for both their allergies and their mental health (like anxiety or depression) have better control over their symptoms. Researchers will look at health records from 200,000 adults over several years. The goal is to understand if com…
Sponsor: QHSLab, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
School air study aims to uncover hidden triggers for Kids' allergies
Knowledge-focused Recruiting nowThis study looks at how indoor air and dust pollutants in classrooms impact children's allergies and lung function. Researchers will monitor 100 children, comparing those with allergies to those without, using questionnaires, allergy tests, and breathing tests. The goal is to ide…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive study tracks 1,000 people to unlock secrets of eczema remission
Knowledge-focused Recruiting nowThis long-term study follows 1,000 people with eczema and related allergies, plus healthy volunteers, to see what factors help the disease go into remission. Researchers will collect medical and lifestyle data to find patterns and possible biomarkers. The goal is to better unders…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New questionnaire aims to simplify allergy tracking in doctor visits
Knowledge-focused Recruiting nowThis study is testing whether a simple symptom score questionnaire (SCST) is acceptable and useful for patients with allergic rhinitis during ENT check-ups. The goal is to see if this tool helps doctors monitor severity and response to treatment consistently. Thirty adults will p…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC